The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience. (Q54699874)
Jump to navigation
Jump to search
scientific article published on 25 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience. |
scientific article published on 25 October 2013 |
Statements
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience. (English)
1 reference
H Kantarjian
1 reference
F Ravandi
1 reference
D Thomas
1 reference
S O'Brien
1 reference
T Kadia
1 reference
J Burger
1 reference
G Borthakur
1 reference
N Daver
1 reference
E Jabbour
1 reference
M Konopleva
1 reference
J Cortes
1 reference
N Pemmaraju
1 reference
M A Kelly
1 reference
M Cardenas-Turanzas
1 reference
R Garris
1 reference
S Faderl
1 reference
25 October 2013
1 reference
1 reference
28
1 reference
973-975
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference